These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11703010)

  • 1. Comparison of ultrasonography and pharmacokinetic analysis of creatine kinase release for quantitative assessment of postinjection muscle damage in sheep.
    Ferré PJ; Concordet D; Laroute V; Chanoit GP; Ferré JP; Manesse M; Lefebvre HP
    Am J Vet Res; 2001 Nov; 62(11):1698-705. PubMed ID: 11703010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release.
    Lefebvre HP; Laroute V; Braun JP; Lassourd V; Toutain PL
    Vet Res; 1996; 27(4-5):343-61. PubMed ID: 8822606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of muscle creatine kinase in sheep. Application to the assessment of local tolerance to injectable veterinary formulations].
    Verlinde V; Mikaelian I; Laurentie M; Sanders P; Poul JM
    Vet Res; 1996; 27(2):133-46. PubMed ID: 8721293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep.
    Houpert P; Serthelon JP; Lefebvre HP; Toutain PL; Braun JP
    Vet Hum Toxicol; 1995 Apr; 37(2):105-10. PubMed ID: 7631487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of tissue lesions after intramuscular injection by determination of creatine kinase in blood].
    Chavez Moreno J; Bickhardt K
    Dtsch Tierarztl Wochenschr; 1997 Dec; 104(12):512-5. PubMed ID: 9451857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic evaluation of intramuscular artesunate in healthy beagle dogs.
    Bennett K; Si Y; Steinbach T; Zhang J; Li Q
    Am J Trop Med Hyg; 2008 Jul; 79(1):36-41. PubMed ID: 18606761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
    Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
    J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local tissue damage after intramuscular injections in rabbits and pigs: quantitation by determination of creatine kinase activity at injection sites.
    Diness V
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):410-5. PubMed ID: 4036633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and residues in milk of oxytetracyclines administered parenterally to dairy goats.
    Rule R; Moreno L; Serrano JM; Roman AG; Moyano R; Garcia J
    Aust Vet J; 2001 Jul; 79(7):492-6. PubMed ID: 11549049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can exercise-induced muscle damage be related to changes in skin temperature?
    da Silva W; Machado ÁS; Souza MA; Kunzler MR; Priego-Quesada JI; Carpes FP
    Physiol Meas; 2018 Oct; 39(10):104007. PubMed ID: 30376452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of creatine kinase activity in dog plasma following intravenous and intramuscular injection of skeletal muscle homogenates.
    Aktas M; Lefebvre HP; Toutain PL; Braun JP
    J Vet Pharmacol Ther; 1995 Feb; 18(1):1-6. PubMed ID: 7752299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography of the equine triceps muscle before and after general anaesthesia and in post anaesthetic myopathy.
    Smith RK; Dyson SJ; Head MJ; Butson RJ
    Equine Vet J; 1996 Jul; 28(4):311-9. PubMed ID: 8818597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels.
    Oukessou M; Uccelli-Thomas V; Toutain PL
    Am J Vet Res; 1992 Sep; 53(9):1658-62. PubMed ID: 1416372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic variables and bioavailability from muscle of creatine kinase in cattle.
    Lefebvre HP; Toutain PL; Serthelon JP; Lassourd V; Gardey L; Braun JP
    Am J Vet Res; 1994 Apr; 55(4):487-93. PubMed ID: 8017694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does increased serum creatine kinase activity reflect exercise-induced muscle damage in rats?
    Komulainen J; Takala TE; Vihko V
    Int J Sports Med; 1995 Apr; 16(3):150-4. PubMed ID: 7649704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of plasma creatine kinase pharmacokinetics to estimate the amount of excercise-induced muscle damage in Beagles.
    Chanoit GP; Lefebvre HP; Orcel K; Laroute V; Toutain PL; Braun JP
    Am J Vet Res; 2001 Sep; 62(9):1375-80. PubMed ID: 11560263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytetracycline concentrations in interstitial fluid from tissue chambers inoculated with
    Washburn KE; Fajt VR; Polasek AN; Lawhon SD; Padgett AL; Lo CP; Mays TP; Washburn SE
    Am J Vet Res; 2019 Jun; 80(6):586-594. PubMed ID: 31140853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase, myosin heavy chains and magnetic resonance imaging after eccentric exercise.
    Sorichter S; Mair J; Koller A; Müller E; Kremser C; Judmaier W; Haid C; Calzolari C; Puschendorf B
    J Sports Sci; 2001 Sep; 19(9):687-91. PubMed ID: 11522144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue residue depletion of oxytetracycline after repeated intramuscular administration of Oxysentin 100 in sheep.
    Fletouris DJ; Papapanagiotou EP
    J Vet Pharmacol Ther; 2009 Feb; 32(1):56-61. PubMed ID: 19161456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.